Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
guidelines minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products
minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
guidelines minimising the risk of transmitting animal spongiform encephalopathy agents via veterinary medicinal products
minimising the risk of transmitting animal spongiform encephalopathy agents via veterinary medicinal products
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
incorrect application of the new eu rules and discriminatory technical solutions and practices could fragment the internal market and increase the risk of inefficiencies and bad governance.
incorrect application of the new eu rules and discriminatory technical solutions and practices could fragment the internal market and increase the risk of inefficiencies and bad governance.
Dernière mise à jour : 2014-10-23
Fréquence d'utilisation : 1
Qualité :
titel på dokumentet note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
título del documento note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
efsa journal (2008) 715, 1-161, scientific opinion on animal health and welfare aspects of avian influenza and the risks of its introduction into the eu poultry holdings.
the efsa journal (2008) 715, p. 1-161: «scientific opinion on animal health and welfare aspects of avian influenza and the risks of its introduction into the eu poultry holdings» (dictamen científico sobre los aspectos de la influenza aviar relacionados con la salud y el bienestar de los animales y los riesgos de su introducción en las explotaciones de aves de corral de la ue).
Dernière mise à jour : 2014-11-13
Fréquence d'utilisation : 1
Qualité :
titel på dokumentet revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file:
título del documento revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file:
Dernière mise à jour : 2011-10-23
Fréquence d'utilisation : 1
Qualité :
Avertissement : cet alignement peut être incorrect.
Veuillez le supprimer, au besoin.
Certaines traductions humaines peu pertinentes ont été masquées.
Affichez les résultats peu pertinents.
